Summit Securities Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-551
Closed -$2.43K 1201
2025
Q1
$2.43K Buy
+551
New +$2.59K ﹤0.01% 658

Other funds holding GDRX

Summit Securities Group's GDRX Position: Q2 2025 in Review

Summit Securities Group sold out of GoodRx Holdings (GDRX) in Q2 2025, closing a stake of 551 shares — an estimated $2.43K sold.

Summit Securities Group first reported a position in GDRX in Q1 2025 and held it in 1 quarter. The position peaked at $2.43K in Q1 2025. 182 funds tracked by Wall St. Rank hold GDRX as of Q2 2025.

  • Summit Securities Group reported no remaining GoodRx Holdings position as of Q2 2025 after selling out during the quarter.
  • Summit Securities Group sold 551 GoodRx Holdings shares in Q2 2025, an estimated $2.43K.
  • Summit Securities Group first reported a position in GoodRx Holdings in Q1 2025 and held it in 1 quarter.
  • Summit Securities Group's GoodRx Holdings position peaked at $2.43K in Q1 2025.
  • 182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2025.

Based on Summit Securities Group's 13F filing for Q2 2025, filed 12 Aug 2025.